Last reviewed · How we verify
NCT02585063
Independent Prescribing Optometrists in Acute Ophthalmic Services
trial in Eye Abnormalities in 321 participants. Completed in 12 September 2018.
13 December 2017
Quick facts
| Lead sponsor | Aston University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 321 |
| Start date | 1 December 2015 |
| Primary completion | 13 December 2017 |
| Estimated completion | 12 September 2018 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Eye Abnormalities — all drugs for Eye Abnormalities →
Sponsor
Aston University
Who can join
18 and older, any sex, with Eye Abnormalities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The UK government's Crown report titled 'Review of prescribing, supply \& administration of medicines' enabled optometrists to train for the qualification of independent prescribing (IP). The UK introduced IP for optometrists in 2009. The proposed research focuses on the role of IP optometrist in the acute ophthalmic services of Manchester Royal Eye Hospital (MREH). The study will compare IP optometrists to consultant ophthalmologists in the ability to diagnose, manage and prescribe medication for patients accessing these services. To achieve this comparison consenting participants will first have a clinical assessment with the IP Optometrist, where findings including diagnosis and management plan will be recorded onto a research proforma. The consultant ophthalmologist will be masked to the IP Optometrist's research proforma to prevent bias. The consultant ophthalmologist will then perform a clinical assessment on a second proforma and inform the participant of their diagnosis and management plan. Percentage agreement, kappa (κ) and weighted κ will be calculated for a range of parameters between the two proformas. Disagreement in diagnosis or management will be arbitrated by a separate ophthalmologist participating in the study with a specialty relevant to the participant's condition. The main objective of the research is to expand the limited base of evidence of of IP optometrists' ability to diagnose, manage and prescribe medication and to determine whether they work at least as safely and effectively as consultant ophthalmologists in acute ophthalmic services. It is the first study in this area since the advent of IP for optometrists, with only one previous study published before IP was introduced. The research will enable the type and frequency of conditions presenting in these services to be measured. Furthermore it will identify conditions that IP optometrists can manage independently and enable guidelines for these conditions to be developed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Agreement in clinical decision-making between independent prescribing optometrists and consultant ophthalmologists in an emergency eye department.
Todd D, Bartlett H, Thampy R, Dhawahir-Scala F, et al · · 2020 · cited 11× · PMID 32203243 · DOI 10.1038/s41433-020-0839-7
Verify or expand the search:
- PubMed search for NCT02585063
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eye Abnormalities
Currently open trials in the same condition.
- NCT06408701 — Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With · recruiting
Other Aston University trials
Trials by the same sponsor.
- NCT07535749 — The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children · Phase 3 · recruiting
- NCT06745375 — Assessment of the Relationship of Soft Contact Lens Fit and Power (Fit & Lens pOwer Soft lenSes) · NA · enrolling by invitation
- NCT07378397 — OPM MEG in Pre-surgical Mapping for Patients With Epilepsy · enrolling by invitation
- NCT06615453 — Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease · NA · recruiting
- NCT06163989 — Protecting the Eyes of Gamers With Lubricating Eyedrops · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02585063 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aston University
- Last refreshed: 14 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02585063.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing